ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 692581 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 692581; 2) Community: the network communities that were significantly associated with the response to NSC 692581; 3) Molecule: the relationships between components within communities and NSC 692581; 4) MDR: the compounds that were significantly associated with the NSC 692581.

NSC Compound Enrichment Correlation
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0462077035966088 0.26904275
NSC 742416 C4, carbonyl, ethyl prodigiosine 0.0462077035966088 0.33300594
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0462077035966088 0.43816699
NSC 744658 6-(p-toluenesulfonylaminoethyl)diquino-1,4-thiazine 0.0462077035966088 -0.22434463
NSC 750440 Null 0.0462077035966088 0.259954
NSC 756169 GSK317314A 0.0462077035966088 0.34439665
NSC 758664 Sirolimus [USAN] 0.0462077035966088 -0.14540255
NSC 249956 CHAPLIATRIN 0.0480633950058471 0.50585842
NSC 303769 Null 0.0480633950058471 0.29883593
NSC 625495 Antimony, dibromo(1-piperidinecarbodithioato-S,S')-, (T-4)- 0.0480633950058471 0.39497904
Total:162  Current:157    [First] [Prev] [Next] [Last]